These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1077 related articles for article (PubMed ID: 1679712)

  • 1. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes.
    Cassell D; Forman J
    J Immunol; 1991 Jan; 146(1):3-10. PubMed ID: 1670605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition by cytotoxic T lymphocytes of Qa-2 antigens. Sensitivity of Qa-2 molecules to phosphatidylinositol-specific phospholipase C.
    Mann D; Forman J
    J Immunol; 1988 Sep; 141(6):1813-8. PubMed ID: 2459191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Ia-unrestricted primary anti-Qa-1 cytotoxic T lymphocyte responses by class II major histocompatibility complex-restricted cellular interactions.
    Huston DP; Tavana G
    J Immunol; 1987 May; 138(9):2753-9. PubMed ID: 3106487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the cytotoxic T lymphocyte response against Qa-1 alloantigens.
    Cassell DJ; Forman J
    J Immunol; 1990 Jun; 144(11):4075-81. PubMed ID: 2140385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
    Vasilakos JP; Michael JG
    J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
    Pilarski LM; Carayanniotis G
    J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells.
    Kos FJ; Müllbacher A
    Eur J Immunol; 1992 Jun; 22(6):1595-601. PubMed ID: 1376266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness.
    Smith PM; Rich RF; Green WR
    Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.
    Boog CJ; Boes J; Melief CJ
    Eur J Immunol; 1988 Feb; 18(2):219-23. PubMed ID: 2965021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
    Yang HY; Dundon PL; Nahill SR; Welsh RM
    J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.